Jaber, J. et al. 2023. Inhaled Epoprostenol Use in Patients with SARS-CoV2-Related Severe Hypoxemic Respiratory Failure. JAP Academy Journal. 1, 3 (Oct. 2023). DOI:https://doi.org/10.58877/japaj.v1i3.58.